Abbott | Capitaux Propres Et Réserves



Equity Capital And Reserves Changement Date
Abbott USD 40.03B 468M 2024-12
Agilent USD 6.03B 129M 2025-01
AtriCure USD 460.97M 4.05M 2024-12
Baxter International USD 6.96B 908M 2024-12
Becton, Dickinson and Co. USD 25.2B 685M 2024-12
Bio-Rad Laboratories USD 6.57B 918.56M 2024-12
Boston Scientific USD 21.77B 1.06B 2024-12
Cooper Companies USD 8.13B 44.1M 2025-01
Danaher USD 49.54B 1.76B 2024-12
Dexcom USD 2.1B 123.6M 2024-12
Edwards Lifesciences USD 10B 452.8M 2024-12
Globus Medical USD 4.18B 107.94M 2024-12
Hologic USD 4.77B 356.7M 2024-12
Insulet USD 1.21B 93.6M 2024-12
Integra LifeSciences USD 1.55B 23.69M 2024-12
Intuitive Surgical USD 16.53B 946.3M 2024-12
J&J USD 71.49B 1.33B 2024-12
Masimo USD 1.05B 411.3M 2024-12
Medtronic USD 49.39B 893M 2025-01
Merit Medical Systems USD 1.38B 55.95M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
Smith & Nephew USD 5.26B 60M 2024-12
Solventum Corp 2.96B 233M 2024-12
Stryker USD 20.63B 485M 2024-12
Tandem Diabetes Care USD 263.1M 25.39M 2024-12
Teleflex USD 4.28B 203.58M 2024-12
Terumo JPY 1.4T 90.06B 2024-12
Thermo Fisher Scientific USD 49.58B 592M 2024-12
Zimmer Biomet Holdings USD 12.47B 93.4M 2024-12



Abbott Capitaux Propres Et Réserves - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Apr 2025.